53BP1 Is Limiting for NHEJ Repair in ATM-deficient Model Systems That Are Subjected to Oncogenic Stress or Radiation

The DNA damage response (DDR) factors ataxia telangiectasia mutated (ATM) and p53 binding protein 1 (53BP1) function as tumor suppressors in humans and mice, but the significance of their mutual interaction to the suppression of oncogenic translocations in vivo has not been investigated. To address this question, the phenotypes of compound mutant mice lacking 53BP1 and ATM (Trp53bp1−/−/Atm−/−), relative to single mutants, were examined. These analyses revealed that loss of 53BP1 markedly decreased the latency of T-lineage lymphomas driven by RAG-dependent oncogenic translocations in Atm−/− mice (average survival, 14 and 23 weeks for Trp53bp1−/−/Atm−/− and Atm−/− mice, respectively). Mechanistically, 53BP1 deficiency aggravated the deleterious effect of ATM deficiency on nonhomologous end-joining (NHEJ)—mediated double-strand break repair. Analysis of V(D)J recombinase-mediated coding joints and signal joints in Trp53bp1−/−/Atm−/− primary thymocytes is, however, consistent with canonical NHEJ-mediated repair. Together, these findings indicate that the greater NHEJ defect in the double mutant mice resulted from decreased efficiency of rejoining rather than switching to an alternative NHEJ-mediated repair mechanism. Complementary analyses of irradiated primary cells indicated that defects in cell-cycle checkpoints subsequently function to amplify the NHEJ defect, resulting in more frequent chromosomal breaks and translocations in double mutant cells throughout the cell cycle. Finally, it was determined that 53BP1 is dispensable for the formation of RAG-mediated hybrid joints in Atm−/− thymocytes but is required to suppress large deletions in a subset of hybrid joints. Implications: The current study uncovers novel ATM-independent functions for 53BP1 in the suppression of oncogenic translocations and in radioprotection. Visual Overview: http://mcr.aacrjournals.org/content/11/10/1223/F1.large.jpg. Mol Cancer Res; 11(10); 1223–34. ©2013 AACR. Visual Overview

[1]  S. Franco,et al.  PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis , 2013, Oncogene.

[2]  Lin Feng,et al.  RIF1 Counteracts BRCA1-mediated End Resection during DNA Repair* , 2013, The Journal of Biological Chemistry.

[3]  Facundo D. Batista,et al.  RIF1 Is Essential for 53BP1-Dependent Nonhomologous End Joining and Suppression of DNA Double-Strand Break Resection , 2013, Molecular cell.

[4]  Adam P. Rosebrock,et al.  A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. , 2013, Molecular cell.

[5]  M. Nussenzweig,et al.  53BP1 alters the landscape of DNA rearrangements and suppresses AID-induced B cell lymphoma. , 2013, Molecules and Cells.

[6]  Michel C. Nussenzweig,et al.  Rif1 Prevents Resection of DNA Breaks and Promotes Immunoglobulin Class Switching , 2013, Science.

[7]  S. B. Buonomo,et al.  53BP1 Regulates DSB Repair Using Rif1 to Control 5′ End Resection , 2013, Science.

[8]  M. Nussenzweig,et al.  RPA accumulation during class switch recombination represents 5'-3' DNA-end resection during the S-G2/M phase of the cell cycle. , 2013, Cell reports.

[9]  M. Dyer,et al.  Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. Shao,et al.  53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-κB through miR-146a. , 2012, Carcinogenesis.

[11]  N. Schultz,et al.  53BP1 is a haploinsufficient tumor suppressor and protects cells from radiation response in glioma. , 2012, Cancer research.

[12]  S. Ganesan,et al.  Low p53 binding protein 1 (53BP1) expression is associated with increased local recurrence in breast cancer patients treated with breast-conserving surgery and radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[13]  T. de Lange,et al.  Removal of Shelterin Reveals the Telomere End-Protection Problem , 2012, Science.

[14]  David Pellman,et al.  Causes and consequences of aneuploidy in cancer , 2012, Nature Reviews Genetics.

[15]  L. Symington,et al.  Double-strand break end resection and repair pathway choice. , 2011, Annual review of genetics.

[16]  Angela T. Noon,et al.  53BP1-mediated DNA double strand break repair: insert bad pun here. , 2011, DNA Repair.

[17]  M. Nussenzweig,et al.  Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. , 2011, Molecular cell.

[18]  S. Desiderio,et al.  Coupling of V(D)J recombination to the cell cycle suppresses genomic instability and lymphoid tumorigenesis. , 2011, Immunity.

[19]  M. Dyer,et al.  The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. , 2010, Blood.

[20]  D. Durocher,et al.  The ubiquitous role of ubiquitin in the DNA damage response , 2010, DNA Repair.

[21]  Jeremy M. Stark,et al.  ATM Limits Incorrect End Utilization during Non-Homologous End Joining of Multiple Chromosome Breaks , 2010, PLoS genetics.

[22]  Michael M. Murphy,et al.  ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification , 2010, The Journal of experimental medicine.

[23]  D. Adams,et al.  53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers , 2010, Nature Structural &Molecular Biology.

[24]  Jeremy M. Stark,et al.  53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks , 2010, Cell.

[25]  M. Nussenzweig,et al.  53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination , 2010, The Journal of experimental medicine.

[26]  S. Franco,et al.  Differential Requirement for H2AX and 53BP1 in Organismal Development and Genome Maintenance in the Absence of Poly(ADP)ribosyl Polymerase 1 , 2010, Molecular and Cellular Biology.

[27]  P. Jeggo,et al.  53BP1 promotes ATM activity through direct interactions with the MRN complex , 2010, The EMBO journal.

[28]  A. Shibata,et al.  53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair , 2010, Nature Cell Biology.

[29]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[30]  F. Alt,et al.  Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes. , 2009, Molecular cell.

[31]  D. Spector,et al.  53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility , 2008, Nature.

[32]  M. Nussenzweig,et al.  53BP1 facilitates long-range DNA end-joining during V(D)J recombination , 2008, Nature.

[33]  M. Lavin,et al.  Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer , 2008, Nature Reviews Molecular Cell Biology.

[34]  C. Bassing,et al.  Aberrant V(D)J Recombination in Ataxia Telangiectasia Mutated-Deficient Lymphocytes Is Dependent on Nonhomologous DNA End Joining1 , 2008, The Journal of Immunology.

[35]  Michael M. Murphy,et al.  DNA-PKcs and Artemis function in the end-joining phase of immunoglobulin heavy chain class switch recombination , 2008, The Journal of experimental medicine.

[36]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[37]  T. Golub,et al.  Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas , 2008, Oncogene.

[38]  J Wade Harper,et al.  The DNA damage response: ten years after. , 2007, Molecular cell.

[39]  M. Nussenzweig,et al.  ATM Prevents the Persistence and Propagation of Chromosome Breaks in Lymphocytes , 2007, Cell.

[40]  B. A. Ballif,et al.  ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage , 2007, Science.

[41]  Fraser McBlane,et al.  Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures. , 2006, DNA repair.

[42]  T. Pandita,et al.  ATM stabilizes DNA double-strand-break complexes during V(D)J recombination , 2006, Nature.

[43]  Michael M. Murphy,et al.  H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. , 2006, Molecular cell.

[44]  Junjie Chen,et al.  p53 Binding Protein 53BP1 Is Required for DNA Damage Responses and Tumor Suppression in Mice , 2003, Molecular and Cellular Biology.

[45]  T. Ried,et al.  Abnormal rearrangement within the α/δ T-cell receptor locus in lymphomas from Atm-deficient mice , 2000 .

[46]  F. Alt,et al.  Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Shridar Ganesan,et al.  Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors. , 2013, Cancer discovery.

[48]  Jiri Bartek,et al.  ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks , 2006, Nature Cell Biology.

[49]  T. Ried,et al.  Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. , 2000, Blood.